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Abstract
Host cells respond to viral infection by many mechanisms, including the production of type I interferons which act in a paracrine and autocrine
manner to induce the expression of antiviral interferon-stimulated genes (ISGs). Viruses have evolved means to inhibit interferon signaling to
avoid induction of the innate immune response. Herpes simplex virus 1 (HSV-1) has several mechanisms to inhibit type I interferon production,
the activities of ISGs, and the interferon signaling pathway itself. We report that the inhibition of the Jak/STAT pathway by HSV-1 requires viral
gene expression and that viral immediate-early protein ICP27 plays a role in downregulating STAT-1 phosphorylation and in preventing the
accumulation of STAT-1 in the nucleus. We also show that expression of ICP27 by transfection causes an inhibition of IFN-induced STAT-1
nuclear accumulation. Therefore, ICP27 is necessary and sufficient for at least some of the effects of HSV infection on STAT-1.
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Type I interferon (IFNα/β) signaling is an important antiviral
response that results in the expression of antiviral, antiproli-
ferative, and immunomodulatory proteins (Platanias and Fish,
1999). IFNα/β binds the type I interferon receptor subunits
(IFNAR-1 and -2), causing heterodimerization and phosphor-
ylation of the subunits. This activation leads to the phosphor-
ylation of the Janus kinases, Jak-1 and Tyk-2, which in turn
phosphorylate signal transducers and activators of transcrip-
tion (STATs) 1 and 2. The STATs heterodimerize and translocate
into the nucleus, where they associate with p48 (also known as
IRF-9), bind a cis-acting DNA element called the interferon-
stimulated response element, or ISRE (Platanias and Fish,
1999); reviewed in Samuel (2001) for the transactivation of⁎ Corresponding author.
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and Biron, 2006).
Several viruses have evolved strategies to evade type I IFN
signaling at different stages of the pathway. Members of the
family Paramyxoviridae block IFN signaling at various steps
(Young et al., 2000), such as by degradation of STAT-1 by
simian virus 5 (Didcock et al., 1999), or inhibition of Janus
kinase activation by Sendai virus (Komatsu et al., 2000). Nipah
virus proteins C, V, and W bind STAT-1 in the cytoplasm or
nucleus and keep it from being activated (Park et al., 2003). The
adenovirus E1A protein blocks signaling upstream of the
formation of ISGF-3 (Leonard and Sen, 1997). Herpes viruses
also have evolved anti-interferon signaling activities. Human
herpesvirus 8 synthesizes an IRF homolog (vIRF) that inhibits
transcription activation, and VZV inhibits expression of STAT-1
(reviewed in Samuel, 2001). Herpes simplex virus 1 (HSV-1)
proteins γ134.5 and ICP0 inhibit interferon signaling by binding
and activating protein phosphatase 1, reversing the block in
translation caused by of PKR (Chou et al., 1995; He et al.,
1997), and by preventing IRF3 nuclear accumulation, thereby
preventing production of IFNβ (Melroe et al., 2004, 2007),
respectively.
Fig. 1. Viral gene expression is required for the inhibition of IFN-induced STAT-
1 phosphorylation by HSV-1. Vero cells were mock-infected or infected with
WTor UV-inactivated WT virus at an MOI of 20 (MOI before UV treatment) for
10 h and treated with IFNα as indicated. Western blot analysis was done with
antibodies to pSTAT-1, STAT-1, ICP27, and actin.
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infection in the mucosal epithelial cells and a life-long latent
infection in neurons, from which it can be reactivated. During
lytic infection, over 80 gene products are expressed in a highly
regulated temporal cascade, immediate-early (IE) proteins
include ICP0, ICP4, ICP22, ICP27, and ICP47 begin to be
expressed as soon as viral DNA enters the nucleus (Honess and
Roizman, 1974, 1975). IE proteins stimulate expression of early
(E) proteins, which are expressed at 5–7 h post infection and are
largely involved in viral DNA replication (Honess and Roiz-
man, 1974). Late genes are divided into two categories: those
that can be expressed without viral DNA replication and those
for which DNA replication is required. These include
glycoproteins and other structural proteins and are expressed
by 8 h post infection (Honess and Roizman, 1974).
Because the innate immune response promotes viral
clearance, it is important for HSV-1 to have processes that
inhibit these pathways in order to productively infect the
epithelial cells, establish latent infection, and persist in neurons
throughout the life of the host. In addition to the mechanisms
outlined above, recent studies have shown that HSV-1 infection
causes a decrease in steady-state STAT-1 phosphorylation in
response to IFNα treatment (Chee and Roizman, 2004; Yokota
et al., 2001, 2005). The virion host shut-off protein (VHS, also
known as UL41) (Chee and Roizman, 2004) and UL13, both
tegument proteins, have been implicated in the decreased sen-
sitivity to IFNα (Yokota et al., 2005), and the mechanism of the
decrease has been proposed to be either induction of suppressor
of cytokine signaling 3 (SOCS-3) expression (Yokota et al.,
2005) or degradation of the type I interferon receptor (Chee and
Roizman, 2004). Here we show that ICP27 is necessary to
decrease STAT-1 phosphorylation and sufficient for at least a
partial block in STAT-1 translocation into the nucleus.
Results
Inhibition of IFNα-induced accumulation of phospho-STAT-1
by HSV-1 requires viral gene expression
Some studies have reported that the virion tegument proteins
UL13 and UL41 account for the HSV-induced inhibition of
IFNα-induced STAT-1 phosphorylation (Chee and Roizman,
2004; Yokota et al., 2004), both these data did not explain the
requirement for gene expression (Yokota et al., 2001) and the
early kinetics of the inhibition of IFNα-induced STAT-1
phosphorylation. To determine if viral tegument proteins were
sufficient for the inhibition of IFNα signaling in our cell system,
we mock-infected or infected Vero cells with WT HSV-1 or UV-
treated HSV-1 at an MOI of 20 (titer of UV-treated virus before
inactivation) for 10 h. Cells were treated as indicated with
104 U/mL IFNα. Mock-infected cells showed a strong phospho-
STAT-1 response to IFNα treatment (Fig. 1, lane 2). HSV-1-
infected cells showed expression of the immediate-early protein
ICP27 (Fig. 1, lanes 3–4) and a very weak phospho-STAT-1
response to IFNα (Fig. 1, lane 4). Cells infected with UV-
inactivated WT HSV-1 did not express ICP27 (Fig. 1, lanes 5–
6) and had a strong phospho-STAT-1 response to IFNαtreatment (Fig. 1, lane 6), similar to that of mock-infected
cells. These results argued that though one or more tegument
proteins may be involved in the inhibition of IFNα-induced
STAT-1, they are not sufficient for this effect without viral gene
expression.
HSV-1 infection inhibits phosphorylation of STAT-1 as early as
2 h post infection
To determine the kinetics of the downregulation of the Jak/
STAT pathway by HSV-1, we mock-infected or infected Vero
cells with the WT strain of HSV-1 for 2, 4, 6, 8, or 10 h and
examined STAT-1 phosphorylation in response to IFNα treat-
ment. Mock-infected cells consistently showed a strong STAT-1
phosphorylation response to IFNα treatment (Fig. 2, lanes 2, 6,
10, 14, 18). However, STAT-1 phosphorylation in HSV-infected
cells was decreased as compared to mock-infected cells at 2 h
post infection (Fig. 2, lane 4) and continued to decrease further
by 4 h post infection (Fig. 2, lane 8), after which it remained
relatively constant.
From these results we concluded that the inhibition of the
Jak/STAT pathway occurred at early times post infection, sug-
gesting that the viral protein or proteins required for the
inhibition of STAT-1 phosphorylation belong to the immediate-
early or early temporal class.
ICP27 is required for inhibition of IFNα signaling
To determine which, if any, immediate-early protein was
required for the inhibition of the Jak/STAT pathway by HSV-1,
we infected cells with WT or mutant viruses defective for IE
genes (Table 1). Mock-infected cells showed a robust STAT-1
phosphorylation response to IFNα treatment (Fig. 3, lane 2)
whereas cells infected with WT HSV-1 showed very little
IFNα-induced STAT-1 phosphorylation (Fig. 3, lane 4). Cells
infected with 5dl1.2, a virus defective for ICP27, showed a
stronger induction of STAT-1 phosphorylation in response to
IFNα treatment than mock-infected cells (Fig. 3, lane 6),
indicating that ICP27 was required for inhibition of STAT-1
phosphorylation. Cells infected with n12 or n199 (ICP4 null
and ICP22 null, respectively) virus showed very little STAT-1
Fig. 2. HSV-1 infection caused reduced phosphorylation of STAT-1 as early as 4 h post infection. Cells were mock-infected or infected with KOS for 2, 4, 6, 8, or 10 h,
and treated with IFNα, as indicated. Western blot analysis was done with antibodies to pSTAT-1, STAT-1, ICP27, and actin.
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respectively), indicating that ICP4 and ICP22 were not required.
In some experiments, cells infected with the ICP0 mutant virus,
n212, showed an intermediate reduction of STAT-1 phosphor-
ylation in response to IFNα (Fig. 2, lane 8) when compared with
mock-infected cells, indicating that ICP0 may play a partial role
in the viral effect on STAT-1 phosphorylation.
To confirm the involvement of ICP27, we mock-infected or
infected Vero or V27 cells with the WT HSV-1 strain KOS1.1,
d27-1, or the rescued virus d27-1R. Mock-infected Vero and
V27 cells showed increased phosphorylation of STAT-1 after
IFNα treatment (Fig. 4A, lane 2, and B, lane 2). WT or d27-1R
virus infection of either cell type showed a dramatic decrease in
IFNα-induced STAT-1 phosphorylation (Fig. 4A, lanes 4, 8,
and B, lanes 4, 8). Infection with d27-1 resulted in very strong
induction of STAT-1 phosphorylation in Vero cells (Fig. 4A,
lane 6) and a much weaker induction in V27 cells (Fig. 4B,
lane 6). The intermediate phospho-STAT-1 signal in d27-1
infected V27 cells could be due to the relatively low levels of
ICP27 expressed (Fig. 4B, lanes 5–6) when compared with the
levels of ICP27 from WT and d27-1R infection in these cells
(Fig. 4B, lanes 2–3, 7–8). These data indicated that ICP27 was
required directly or indirectly for the downregulation of STAT-1
phosphorylation in response to IFNα treatment during HSV-1
infection.
A role for the vhs function in the block of the Jak/STAT
pathway has been proposed (Chee and Roizman, 2004; Yokota
et al., 2004). To determine if the host shut-off function of vhs
was required for the inhibition of IFNα-induced STAT-1 phos-
phorylation, we mock-infected or infected Vero and V27 cells
with WT-virus or vhs-1 mutant virus. At 10 hpi, cells wereTable 1
HSV-1 mutant viruses defective for immediate-early genes
Mutant virus IE gene mutated Reference
5dl1.2 ICP27 McCarthy et al. (1989)
n12 ICP4 DeLuca and Schaffer (1988)
n212 ICP0 Cai and Schaffer (1989)
n199 ICP22 Rice and Knipe (1988)treated with IFNα as indicated. In both Vero and V27 cells
infected with the VHS mutant virus, IFNα-induced STAT-1
phosphorylation was blocked to WT-virus infection levels
(Figs. 4A, lanes 3–4, 9–10, 3B, lanes 3–4, 9–10). The vhs-1
mutant virus did exhibit a defect in host protein synthesis shut-
off (Fig. 4C, lanes 3, 6, 9), as shown originally (Read and
Frenkel, 1983). These data indicated that host shut-off is likely
not required for the inhibition of the Jak/STAT pathway for this
strain of HSV-1 in Vero cells.
ICP27 is necessary for the inhibition of nuclear accumulation
of STAT-1 in response to IFNα
To determine the stage at which HSV-1 and ICP27 acted to
inhibit IFNα-signaling, we examined the nuclear translocation
of STAT-1. In response to IFNα treatment, STAT-1 translocated
from a diffuse cytoplasmic and nuclear distribution to an almost
completely nuclear localization in mock-infected cells (Fig. 5,
panels A, D). In WT virus-infected cells, STAT-1 remained
cytoplasmic in both untreated and IFNα treated cells (Fig. 5,
panels B, E) and appeared to form perinuclear spots for both
conditions. Cells infected with 5dl1.2 (ICP27−) virus showed
nuclear translocation of STAT-1 (Fig. 5, panels C, F) similar to
that seen after mock infection. These data indicated that ICP27
was necessary not only for the decrease in IFNα-inducedFig. 3. ICP27 is necessary to block STAT-1 phosphorylaton in response to IFNα.
Cells were infected with viruses with mutations in immediate-early genes (see
Table 1) for 10 h and treated with IFNα for 30 min prior to lysis. Western blot
analysis was done with antibodies to pSTAT-1, and STAT-1.
Fig. 4. ICP27 but not the host shut-off function of vhs is required for HSV-1 inhibition of the Jak/STAT pathway. Vero (A) and V27 (B) cells were mock-infected or
infected with the WT HSV-1 KOS1.1 strain, d27-1, d27-1R, or VHS. 30 min before harvest, samples were treated with IFNα at 104U/mL (even lanes). Western blot
analysis was done with antibodies to pSTAT-1, STAT-1, ICP27, and actin. To ensure the defect in host shut-off of vhs-1, cells were mock-infected or infected with KOS
(wt) or vhs-1 for 2, 4, or 6 h, then incubated with [35S]-met for 30 min. Shown (C) is an autoradiograph of the cell lysates separated on a 9.5% polyacrylamide gel.
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inhibition of STAT-1 nuclear accumulation.
ICP27 is sufficient to block nuclear translocation of STAT-1 in
response to IFNα
We observed that ICP27 was necessary for the HSV-1-
induced block in STAT-1 activation and nuclear translocation.
To determine if ICP27 was sufficient to block nuclear trans-
location of STAT-1, we transfected Vero cells with empty vectorFig. 5. ICP27 is necessary to block the nuclear translocation of STAT-1 in response to
MOI of 20 for 10 h. At 30 min prior to fixation, cells were treated with 104 U/mL IFN
Alexafluor 488 anti-rabbit secondary antibodies. Immunofluorescence images are shplasmid (pCI) or pCI-ICP27 plasmid and then treated the cells
with IFNα. In cells transfected with pCI, IFNα treatment caused
STAT-1 to redistribute from diffuse localization throughout
the cell (Fig. 6, panels A, I) to almost exclusively nuclear
localization (Fig. 6, panels B, J). In cells that expressed ICP27,
ICP27 staining was mostly nuclear (Fig. 6, panels G, H, K, L), as
in previous reports (Rice and Knipe, 1990), and STAT-1 staining
was diffuse throughout the cell regardless of IFNα treatment
(Fig. 6, panels C, D, K, L) in 100% of cells expressing trans-
fected ICP27 (n=236). Many cells that did not express ICP27IFNα. Vero cells were mock-infected or infected with KOS or 5dl1.2 virus at an
α. Immunofluorescence was done with a polyclonal rabbit antibody to Stat-1 and
own.
Fig. 6. ICP27 expression is sufficient to block nuclear translocation of STAT-1. Vero cells were transfected with pCI (A, B, E, F, I, J) or with pCI-ICP27 (C, D, G, H, K,
L). After 24 h, cells were treated with 104 U/mL human IFNα (B, D, F, H, J, L) for 30 min. Cells were immunostained with mouse monoclonal antibodies to ICP27 and
rabbit polyclonal antibodies to STAT-1, and Alexafluor 488 anti-mouse and Alexafluor 594 anti-rabbit secondary antibodies. Immunofluorescence images are shown.
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obviously express ICP27 had more diffuse STAT-1 staining
(Fig. 6, panels D, H, L). These data argued that ICP27 is suf-
ficient for at least a partial block of the Jak/STAT pathway.
Discussion
HSV-1 has several mechanisms to evade the effects of
interferon signaling, including inhibition of IFNβ production by
blocking IRF-3 nuclear accumulation (Melroe et al., 2004),
counteracting the effects of PKR activity through the activation
of protein phosphatase 1 by γ134.5 (Chou et al., 1995; He et al.,
1997), and inhibition of IFNα-induced STAT-1 phosphorylation
(Yokota et al., 2001). In this study we show that the effects of
HSV-1 on Jak/STAT signaling occur early in infection, that
ICP27 is necessary for the inhibition of both the phosphoryla-
tion and nuclear accumulation of STAT-1, and that ICP27 is
sufficient for at least a partial block in nuclear accumulation of
STAT-1.
ICP27 is necessary for the inhibition of IFNα-induced STAT-1
phosphorylation by HSV-1
Consistent with previous reports (Yokota et al., 2001), our
data show that IFNα-induced phosphorylation of STAT-1 is
blocked as early as 2 h post infection. Expression of HSV-1
proteins has been shown to be important to block Jak/STAT
signaling (Yokota et al., 2001); therefore, we can conclude thatthe viral proteins involved in this inhibition belong to the
immediate-early or early temporal classes. From the results of
our tests of IE mutant viruses, ICP27 is required for the decrease
in phosphorylated STAT-1, indicating a role for ICP27 in the
inhibition of the Jak/STAT pathway by HSV-1. This is
consistent with a recent study in which ICP27 was shown to
be necessary for HSV-1 to cause a decrease in cytokine
production by infected cells (Melchjorsen et al., 2006), as many
cytokine genes are induced in response to IFNα signaling (Der
et al., 1998). The possibility of a role for ICP27 in the inhibition
of the Jak/STAT pathway was discussed by Chee and Roizman
in conjunction with their studies using a vhs mutant virus (Chee
and Roizman, 2004) as ICP27 has been shown to aid in the shut-
off of host cell protein expression (Hardwicke and Sandri-
Goldin, 1994; Sacks et al., 1985). We propose that the role for
ICP27 is independent of the role in host protein synthesis shut-
off as the experiments we have done with a vhs mutant virus
showed inhibition of IFNα-induced STAT-1 phosphorylation to
similar to that induced during WT-infection.
The reduced STAT-1 phosphorylation response to IFNα
treatment in cells infected with the ICP0 mutant could indicate
that ICP0 is also involved in the inhibition of the Jak/STAT
pathway. ICP0 has been shown to have many activities to
counteract various stages of IFN signaling (Halford et al., 2006;
Melroe et al., 2004; Mossman, 2005; Sobol and Mossman, 2006)
but because ICP27 expression is sufficient to inhibit IFNα-
induced nuclear accumulation of STAT-1, it seems that any role
ICP0 might play in this process is secondary to that of ICP27.
492 K.E. Johnson et al. / Virology 374 (2008) 487–494Inhibition of type I IFN signaling by HSV-1 occurs with very
limited viral gene expression
Because ICP27 has several reported functions in viral
replication and many binding partners, it was important to
determine if ICP27 was sufficient for inhibition of type I IFN
signaling. Our transfection studies with an ICP27 expression
vector showed at least a partial block in STAT-1 translocation
into the nucleus of ICP27 expressing cells. We were not able to
determine the phosphorylation state of STAT-1 in cells trans-
fected with ICP27 byWestern blot because of the low frequency
of transfected cells that expressed ICP27.
During infection, ICP27 shuttles between the nucleus and
cytoplasm but is predominantly nuclear (Ackermann et al.,
1984; Knipe et al., 1987; Wilcox et al., 1980). Because ICP27
expression blocks nuclear accumulation of STAT-1, it seems
unlikely that the mechanism by which ICP27 blocks Jak/STAT
signaling occurs by a physical interaction between ICP27 and
STAT-1. In transfected cells that showed cytoplasmic ICP27
localization, STAT-1 was also largely cytoplasmic, so it is
unlikely that ICP27 is binding and sequestering in the nucleus a
factor in the Jak/STAT pathway upstream of Stat activation.
ICP27 has been shown previously to affect the phosphoryla-
tion state of viral (Xia et al., 1996) and cellular proteins (Fraser
and Rice, 2005; Kim and DeLuca, 2002; Koffa et al., 2003;
Sciabica et al., 2003), though few mechanisms have yet been
determined. ICP27 inhibits splicing of cellular mRNAs by
recruiting a normally cytoplasmic kinase, SRPK1 to the nucleus
and causing the hypo-phosphorylation of the SR proteins, thus
rendering them less active (Sciabica et al., 2003). It is possible
that ICP27 is recruiting one or both of the Janus kinases to the
nucleus, which would result in the inhibition of the Jak/STAT
pathway and, because correct Tyk-2 expression and localization
is important for IFNAR localization to the plasma membrane
(Ragimbeau et al., 2003), it is possible that this would result in
the internalization of IFNAR.
In conclusion, we have shown that ICP27 is necessary for the
inhibition of type I interferon signaling byHSV-1 and is sufficient
for at least a partial block in the nuclear accumulation of STAT-1.
Further investigation of the role of ICP27 in the inhibition of
IFNα signaling should provide additional insight into the mech-
anisms of innate immune system evasion by HSV-1.
Materials and methods
Cells and viruses
Vero and V27 cells (Vero cells stably transfected with the
ICP27 gene) which is expressed following HSV-1 infection
(Rice and Knipe, 1990) were maintained in Dulbecco's
modified Eagle's medium (DMEM, Gibco-BRL) supplemented
with 5% heat-inactivated fetal calf serum (FCS) and 5% heat-
inactivated newborn calf serum (BCS).
Viral stocks were grown in the appropriate complementing
cell lines (the HSV-1 WT KOS and KOS1.1 strains, d27-1R,
n199 and vhs-1 (Read and Frenkel, 1983) were grown on
Vero cells, 5dl1.2 (McCarthy et al., 1989) and d27-1 (Rice andKnipe, 1990) on V827 cells, d106 and n12 on E11 cells
(DeLuca and Schaffer, 1988; Samaniego et al., 1997), and n212
on U2OS cells (Cai and Schaffer, 1989). Viral titers were
determined by plaque assay in Vero cells or the indicated
complementing cell line as described (Knipe and Spang, 1982).
For infection experiments, viruses were used at an MOI of 20
to infect Vero and V27 cells, which were incubated at 37 °C in
PBS with 1% BCS, 0.1% glucose for 1 h before removal of the
inoculum and addition of DMEM supplemented with 1% FCS.
For UV inactivation, WT virus was diluted to 108 pfu/mL in
PBS and exposed to shortwave ultraviolet light for 30 min prior
to infection. Viral titer was reduced by 4 logs. Infections with
UV-inactivated virus was based on titer before UV-irradiation.
Plasmids and transfections
Plasmid pCI was obtained from Promega. Plasmid pCI-
ICP27 has been described previously (Olesky et al., 2005). At
24 h before transfection, Vero cells were seeded into 6-well
plates containing glass coverslips for fluorescence experiments.
Transfections were carried out using Opti-MEM media (Gibco)
and Genejuice reagent (Novagen) according to the manufac-
turer's instructions.
Western blots
Mock-infected or infected cells were harvested from 25-cm2
flasks in 400 μL of SDS sample buffer (62.5 mM Tris–HCl pH
6.8, 20% glycerol, 2% SDS, 0.1% bromophenol blue, 10 mM
β-glycerophosphate, 5 mM sodium fluoride, 1 mM sodium
vanadate, 0.5% β-mercaptoethanol) and separated by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis in 12% bis-
crosslinked polyacrylamide gels and electrically transferred to
nitrocellulose in transfer buffer (25 mM Tris, 192 mM glycine,
20% methanol) overnight at 4 °C with the Bio-Rad Transblot
system. Membranes were probed with antibodies to STAT-1
(1:1000), pSTAT-1 (1:500), actin (1:200) from Santa Cruz
Biotechnology, Inc, or ICP27 (H1119 at 1:10,000) from Virusys
in PBST (0.5% Tween 20 in PBS from Gibco), washed twice for
5 min in PBST, and incubated with secondary antibodies
conjugated to horseradish peroxidase (HRP) diluted 1:5000–
1:20,000 from Santa Cruz.Biotechnology, Inc. HRP activity
was detected using Western Lightening chemiluminescence
reagent (PerkinElmer) and exposed on X-ray film (Kodak).
Antibodies and immunofluorescence
Secondary antibodies conjugated to Alexa 594 and Alexa
488 dyes were obtained from Molecular Probes Inc.
Vero cells were seeded for immunofluorescence at 5×105
cells/well on glass coverslips in 6-well plates and incubated
overnight at 37 °C before infection or transfection. Following
incubation for the appropriate time, cells were fixed in 3.7%
formaldehyde in phosphate-buffered saline (PBS) for 10 min at
room temperature, and cells were permeabilized by incubation
in methanol at −20 °C for 2 min. Following several washes in
PBS, cells were blocked overnight in IF buffer (PBS containing
493K.E. Johnson et al. / Virology 374 (2008) 487–4942.5% goat serum [Sigma]). Primary antibodies were diluted
appropriately (STAT-1 1:50, ICP27 1:750) and applied to cells
in PBS, and the cells were incubated for 45 min at 37 °C. Cells
were washed twice for 5 min in PBS. Secondary antibodies
were applied at 1:1000 in PBS for 30 min at 37 °C. Cells were
then washed twice for 10 min in PBS at room temperature, and
coverslips were mounted with Prolong antifade reagent
(Molecular Probes, Inc.).
Slides were viewed with an Axioplan 2 microscope (Zeiss)
with a 63× objective and a 10× ocular objective. Images were
collected with the Axiovision 4.5 suite of programs (Zeiss) and
a Hamamatsu C4742-95-12NR digital camera.
Labeling of proteins with [35S]-methionine
Vero cells in 100 mm dishes were mock-infected or infected
with KOS or vhs-1 at an MOI of 20 for 2, 4, or 6 h at which
point the media was replaced with 3 mL cysteine/methionine-
deficient media containing 300 μCi [35S]-met per dish for
30 min. Cells were harvested, lysed in 500 μL of SDS sample
buffer and 85 μL of each lysate was separated using SDS-PAGE
on a 9.5% DATD-crosslinked polyacrylamide gel. The gel was
dried and exposed on X-ray film for autoradiography.
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